J&J Medical Connect
ZYTIGA®

(abiraterone acetate)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

ZYTIGA® (abiraterone acetate)
Medical Information

Administration of ZYTIGA via a Feeding Tube

Last Updated: 07/29/2026

Summary

  • The company cannot recommend any practices, procedures, or usage that deviate from the approved labeling.
  • Data from pharmacokinetic and pharmacodynamic studies of splitting or crushing ZYTIGA tablets for administration are not available. Data on administration via a feeding tube (eg, nasogastric tube [NG-tube], gastric tube [G-tube], jejunal tube [J-tube]) are also not available.

LITERATURE SEARCH

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 15 June 2026.

Would you like to clear and leave your conversation? Message history will be lost.